Jacobs Levy Equity Management’s NuVasive, Inc. NUVA Stock Holding History

Jacobs Levy Equity Management’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,915	Closed	-$904K	–	1092
2022 Q4	$904K	Buy	+21,915	New	+$887K	0.01%	693
2017 Q1	–	Sell	-6,050	Closed	-$408K	–	1027
2016 Q4	$408K	Sell	6,050 -30	-0.5%	-$1.93K	0.01%	719
2016 Q3	$405K	Hold	6,080	–	–	0.01%	751
2016 Q2	$363K	Buy	+6,080	New	+$329K	0.01%	839
2014 Q2	–	Sell	-47,170	Closed	-$1.81M	–	956
2014 Q1	$1.81M	Buy	+47,170	New	+$1.73M	0.03%	418
2013 Q4	–	Sell	-70,755	Closed	-$1.73M	–	1056
2013 Q3	$1.73M	Sell	70,755 -207,345	-75%	-$5.1M	0.03%	434
2013 Q2	$6.89M	Buy	+278,100	New	+$6.08M	0.12%	222

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Jacobs Levy Equity Management's NUVA Position: Q1 2023 in Review

Jacobs Levy Equity Management sold out of NuVasive, Inc. (NUVA) in Q1 2023, closing a stake of 21,915 shares — an estimated $904K sold.

Jacobs Levy Equity Management first reported a position in NUVA in Q2 2013 and held it in 7 quarters. The position peaked at $6.89M in Q2 2013. 241 funds tracked by Wall St. Rank hold NUVA as of Q1 2023.

Jacobs Levy Equity Management reported no remaining NuVasive, Inc. position as of Q1 2023 after selling out during the quarter.
Jacobs Levy Equity Management sold 21,915 NuVasive, Inc. shares in Q1 2023, an estimated $904K.
Jacobs Levy Equity Management first reported a position in NuVasive, Inc. in Q2 2013 and held it in 7 quarters.
Jacobs Levy Equity Management's NuVasive, Inc. position peaked at $6.89M in Q2 2013.
241 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2023, filed 15 May 2023.